Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Élasticité du tissu adipeux abdominal et des membres inférieurs chez les patients atteints de lipœdème

17 novembre 2026 mis à jour par: Fatih Sultan Mehmet Training and Research Hospital

Élasticité du tissu adipeux abdominal et des membres inférieurs chez les patients atteints de lipœdème : une étude par élastographie par ondes de cisaillement

Lipedema is a chronic disorder characterized by abnormal bilateral fat deposition in the extremities, predominantly affecting women and typically beginning at puberty. The trunk, hands, and feet are usually spared. Despite its relatively high prevalence, lipedema is frequently underrecognized in clinical practice and is often confused with conditions such as obesity, venous insufficiency, and lymphedema. Patients commonly present with pain, tenderness, and easy bruising.

Current imaging methods have demonstrated increased subcutaneous tissue thickness and fluid infiltration in lipedema; however, no imaging modality has yet been established as a definitive diagnostic tool. Shear wave elastography (SWE) is a noninvasive ultrasound-based technique that enables quantitative assessment of tissue stiffness and may provide additional information regarding tissue structure and mechanical properties.

In this study, we aim to compare lower extremity subcutaneous tissue stiffness in patients with lipedema and healthy controls using SWE. As a secondary objective, we aim to evaluate abdominal subcutaneous tissue stiffness in patients with lipedema and compare these findings with both lower extremity measurements in the same patients and abdominal measurements in individuals without lipedema.

Aperçu de l'étude

Statut

Complété

Les conditions

Description détaillée

Lipedema is a disorder characterized by abnormal bilateral fat deposition in the upper and lower extremities, typically beginning at puberty and predominantly affecting women. Its prevalence in the female population is estimated to be approximately 11%. The condition primarily involves the extremities, while the trunk, hands, and dorsum of the feet are typically spared. It has a genetic predisposition and is influenced by hormonal factors. Despite being relatively common, lipedema is frequently overlooked in daily clinical practice. Therefore, accurate clinical recognition of the disease is essential. In the differential diagnosis, it is often confused with obesity, venous insufficiency, and lymphedema. The main symptoms reported by patients with lipedema include pain, tenderness, and easy bruising.

Previous imaging studies using Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) have demonstrated thickening of the subcutaneous tissue without muscle edema, along with fluid infiltration within adipose tissue.

Ultrasonography (US) provides rapid and reliable diagnosis for many musculoskeletal lesions. Due to its ease of use, absence of radiation, and cost-effectiveness, it has become a preferred modality in musculoskeletal imaging. Elastography techniques vary depending on the method of compression, tissue displacement characteristics, and image acquisition techniques. The main types used in clinical practice include strain (compression) elastography, acoustic radiation force, shear wave elastography (SWE), and transient elastography. In addition to providing morphological information, SWE allows quantitative measurement of tissue elasticity and offers valuable insights into mechanical properties related to degeneration, injury, and healing.

This technology represents an ultrasound-based counterpart of manual palpation used by clinicians for tissue characterization. SWE is one of the ultrasound elastography techniques that utilizes shear wave speed (SWS) to assess tissue stiffness. During real-time B-mode ultrasonography, localized transient displacements in the tissue are generated by short-duration acoustic push pulses, producing shear waves. The propagation speed of these waves (SWS) is then recorded.

Measurements can be expressed in meters per second (m/s) or kilopascals (kPa), depending on the system. The square root of tissue elasticity is proportional to SWS, which directly correlates with tissue stiffness. This implies that stiffer tissues allow faster propagation of shear waves. Extracellular matrix components, particularly fibrotic deposits such as collagen, are the primary determinants of tissue stiffness. Ultrasound elastography has been established as an excellent diagnostic modality for conditions such as liver fibrosis, breast cancer, and thyroid cancer. In the field of musculoskeletal medicine, numerous studies have been conducted since the early 1990s, and its clinical application has increased in recent years .

In ultrasonographic studies of lipedema, no significant differences have been observed in the dermis, whereas increased thickness and decreased echogenicity of the subcutaneous tissue have been reported . However, there are currently no studies in the literature investigating lipedema using SWE. An imaging modality that definitively supports the clinical diagnosis of lipedema has not yet been established. The diagnostic performance of existing imaging methods remains limited. Prospective studies are needed to evaluate and compare the diagnostic performance of different imaging techniques. There is also a need for imaging modalities that focus on the pathophysiology of the disease .

In this study, we aimed to compare the stiffness of lower extremity subcutaneous tissue in patients with lipedema, characterized by diffuse subcutaneous tissue expansion, with that of a healthy population using SWE. As a secondary objective, we aimed to evaluate abdominal subcutaneous tissue stiffness using SWE in patients with lipedema and to compare it with both the lower extremity measurements in lipedema patients and the abdominal subcutaneous tissue stiffness in individuals without lipedema.

Type d'étude

Observationnel

Inscription (Réel)

95

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Ataşehir
      • Istanbul, Ataşehir, Turquie (Türkiye), 34752
        • Fatih Sultan Mehmet Education and Training Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Femelle

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Women aged ≥18 years with lipedema (stages 1-3) and healthy controls were included.

La description

Inclusion Criteria:

  • Women aged ≥18 years with lipedema (stages 1-3) and healthy controls with adequate cognitive function

Exclusion Criteria:

  • Age <18 years Lymphedema Edema of cardiac or nephrogenic origin Diabetes mellitus Thyroid dysfunction Oncological diseases Polyneuropathy or radiculopathy Advanced degenerative diseases affecting the extremities Use of antiepileptic or antidepressant drugs within the last 6 months Use of edema-inducing medications (e.g., corticosteroids, calcium channel blockers, gabapentin, pregabalin) Cognitive impairment preventing participation

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Modèles d'observation: OTHER
  • Perspectives temporelles: CROSS_SECTIONAL

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
lipedema group

Women aged ≥18 years with lipedema (stages 1-3)

Tissue elasticity was assessed using shear wave elastography (SWE) by a radiologist with 18 years of experience, using an RS 85 US device (Samsung Medison, Seoul, Korea) with an SL 10-2 linear probe. Patients were examined in the supine position, and a 10-mm layer of high-viscosity gel was applied to minimize compression. Bilateral measurements were obtained from four sites (anterior thigh, pretibial region, lateral leg, and abdomen), with three measurements per site averaged for analysis.

control group

healty controls

Tissue elasticity was assessed using shear wave elastography (SWE) by a radiologist with 18 years of experience, using an RS 85 US device (Samsung Medison, Seoul, Korea) with an SL 10-2 linear probe. Patients were examined in the supine position, and a 10-mm layer of high-viscosity gel was applied to minimize compression. Bilateral measurements were obtained from four sites (anterior thigh, pretibial region, lateral leg, and abdomen), with three measurements per site averaged for analysis.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Tissue elasticity, as measured by shear-wave elastography (SWE)
Délai: 1 day

Comparison of tissue elasticity at the specified sites in both legs between patients with lipedema and healthy controls

1 day

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Tissue elasticity, as measured by shear-wave elastography (SWE)
Délai: 1 day

The elasticity of subcutaneous adipose tissue in the abdominal region and legs should be measured in patients with lipedema."

1 day

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Feyza Akan Begoğlu, Fatih Sultan Mehmet Education and Training Hospital

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 janvier 2025

Achèvement primaire (Réel)

1 mars 2026

Achèvement de l'étude (Réel)

1 mars 2026

Dates d'inscription aux études

Première soumission

11 avril 2026

Première soumission répondant aux critères de contrôle qualité

11 avril 2026

Première publication (Réel)

17 avril 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

17 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • Shearwave study

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner